Literature DB >> 10083329

Specific inhibition of CD26/DPP IV enzymatic activity in allograft recipients: effects on humoral immunity.

S Korom1, I De Meester, G Schmidbauer, J Pratschke, M D Brendel, C Durinx, K Schwemmle, A Haemers, S Scharpé, J W Kupiec-Weglinski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10083329     DOI： 10.1016/s0041-1345(98)02069-7

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  2 in total

Review 1.  Dipeptidyl peptidase IV activity and/or structure homologs: contributing factors in the pathogenesis of rheumatoid arthritis?

Authors:  Aleksi Sedo; Jonathan S Duke-Cohan; Eva Balaziova; Liliana R Sedova
Journal:  Arthritis Res Ther       Date:  2005-10-26       Impact factor: 5.156

2.  Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responses.

Authors:  Kalpit A Vora; Gene Porter; Roche Peng; Yan Cui; Kellyann Pryor; George Eiermann; Dennis M Zaller
Journal:  BMC Immunol       Date:  2009-04-09       Impact factor: 3.615
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.